ANTIHYPERTENSIVE AND RENAL EFFECTS OF ENALAPRIL AND SLOW-RELEASE VERAPAMIL IN ESSENTIAL-HYPERTENSION - A DOUBLE-BLIND, RANDOMIZED STUDY

被引：5
|
作者：
FAGHER, B
HENNINGSEN, N
HULTHEN, L
KATZMAN, P
THULIN, T
机构：
[1] UNIV LUND, MALMO GEN HOSP, DEPT MED, S-21401 MALMO, SWEDEN
[2] UNIV LUND, MALMO GEN HOSP, DEPT ENDOCRINOL, S-21401 MALMO, SWEDEN
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1990年 / 39卷
关键词：
Enalapril; hypertension; renal function; verapamil;
D O I：
10.1007/BF01409207
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The renal, metabolic and antihypertensive effects of enalapril (E) and slow-release verapamil (V) were compared in a 2-month double-blind crossover trial in 22 patients with newly discovered essential hypertension. The glomerular filtration rate and renal vascular resistance were unaltered; renal blood flow was slightly decreased by V Serum Ca2+ increased and Na+ excretion declined after V. Serum lipids, glucose, and erythrocyte electrolytes were unchanged. Blood pressure (BP) was lower with E after half the maximum dosage compared with V but similar BP reductions were obtained after 2 months with the maximum dosage. © 1990 Springer-Verlag.
引用
收藏
页码：S41 / S43
页数：3
相关论文
共 50 条
  • [31] DOUBLE-BLIND RANDOMIZED CROSSOVER TRIAL OF MODERATE SODIUM RESTRICTION IN ESSENTIAL-HYPERTENSION
    MACGREGOR, GA
    BEST, FE
    CAM, JM
    MARKANDU, ND
    ELDER, DM
    SAGNELLA, GA
    SQUIRES, M
    LANCET, 1982, 1 (8268): : 351 - 355
  • [32] A RANDOMIZED DOUBLE-BLIND CLINICAL-TRIAL OF XIPAMID AND HYDROCHLOROTHIAZIDE IN ESSENTIAL-HYPERTENSION
    KUMAR, S
    PANDHI, P
    WAHI, PL
    SHARMA, PL
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1984, 22 (10) : 549 - 551
  • [33] SLOW-RELEASE METOPROLOL, HYDROCHLOROTHIAZIDE AND HYDRALAZINE IN STEPWISE TREATMENT OF ESSENTIAL-HYPERTENSION
    HOUTZAGERS, JJR
    DOLS, DM
    MEEMS, L
    NETHERLANDS JOURNAL OF MEDICINE, 1984, 27 (08): : 287 - 292
  • [34] LONG-TERM TREATMENT OF ESSENTIAL-HYPERTENSION WITH SLOW-RELEASE NIFEDIPINE
    ARRIGO, F
    CONSOLO, F
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 41 (05): : 651 - 664
  • [35] A COMPARATIVE-STUDY OF CARVEDILOL, SLOW-RELEASE NIFEDIPINE, AND ATENOLOL IN THE MANAGEMENT OF ESSENTIAL-HYPERTENSION
    HALL, S
    PRESCOTT, RI
    HALLMAN, RJ
    DIXON, S
    HARVEY, RE
    BALL, SG
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 : S35 - S38
  • [36] LONG-TERM THERAPY WITH SLOW-RELEASE NIFEDIPINE IN ESSENTIAL-HYPERTENSION
    ARRIGO, F
    CONSOLO, F
    CARDIOVASCULAR DRUGS AND THERAPY, 1990, 4 : 941 - 946
  • [37] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PARALLEL STUDY OF VARIOUS DOSES OF LOSARTAN POTASSIUM COMPARED WITH ENALAPRIL MALEATE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    GRADMAN, AH
    ARCURI, KE
    GOLDBERG, AI
    IKEDA, LS
    NELSON, EB
    SNAVELY, DB
    SWEET, CS
    HYPERTENSION, 1995, 25 (06) : 1345 - 1350
  • [38] ANTIHYPERTENSIVE EFFECT OF A NEW FORMULATION OF SLOW RELEASE OXPRENOLOL IN ESSENTIAL-HYPERTENSION
    POMIDOSSI, G
    PARATI, G
    MALASPINA, D
    CAMESASCA, C
    MOTOLESE, M
    ZANCHETTI, A
    MANCIA, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 (05) : 593 - 598
  • [39] A DOUBLE-BLIND MULTICENTER STUDY OF PIRETANIDE AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    BUCKERT, C
    MUHLHAUSLER, W
    FRATZER, U
    VERHO, M
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1984, 12 (02) : 81 - 86
  • [40] DOUBLE-BLIND CROSSOVER STUDY OF FENQUIZONE COMPARED TO CHLORTHALIDONE IN ESSENTIAL-HYPERTENSION
    ANGELINO, PF
    ALVINODEMARTINO, A
    MAPPA, R
    DONATI, C
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1985, 23 (09) : 501 - 505
12345